Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eleni
Eleni Bitziou, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20120091008 | PH MEASUREMENT DEVICE - A fluid sampling element is adapted to receive a fluid sample, but also includes a pH sensor element adapted to measure pH of the fluid sample and a reference sensor element. The pH sensor element and the reference sensor element are adapted to generate a potential difference between each other based on the pH of the fluid sample. The pH of the fluid sample can be measured and the fluid sampling element can then be readily disposed of. | 04-19-2012 |
Eleni Diamanti, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20100034390 | Differential Phase Shift Keying Quantum Key Distribution - Differential phase shift (DPS) quantum key distribution (QKD) is provided, where the average number of photons per transmitted pulse is predetermined such that the secure key generation rate is maximal or nearly maximal, given other system parameters. These parameters include detector quantum efficiency, channel transmittance and pulse spacing (or clock rate). Additional system parameters that can optionally be included in the optimization include baseline error rate, sifted key error rate, detector dead time, detector dark count rate, and error correction algorithm performance factor. The security analysis leading to these results is based on consideration of a hybrid beam splitter and intercept-resend attack. | 02-11-2010 |
Eleni Dokou, Harleysville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100081642 | CB-1 RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS - The present invention relates to pharmaceutical compositions that stabilize and improve the bioavailability of 3-[(1S)- 1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile. In particular, the present invention relates to pharmaceutical compositions that include 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3 -(5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile and at least one pharmaceutical acceptable excipient, such as a mono-, di- or triglyceride. | 04-01-2010 |
| 20100209496 | LIQUID AND SEMI-SOLID PHARMACEUTICAL FORMULATIONS FOR ORAL ADMINISTRATION OF A SUBSTITUTED AMIDE - 3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2H-isoindol-2-yl]cyclopent-2-en-1-one (Compound I) has surprisingly improved solubility, bioavailability and stability in an ampiphilic vehicle that can include propylene glycol, a propylene glycol sparing agent, an antioxidant, or a mixture thereof. In one embodiment of the present invention is a solution comprising the active or a pharmaceutically acceptable salt or solvate thereof, and an amphiphilic agent, said amphiphilic agent being a fatty acid ester of glycerol, propylene glycol or sorbitol. | 08-19-2010 |
Eleni Dokou, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110236478 | CO-CRYSTALS AND PHARMACEUTICAL FORMULATIONS COMPRISING THE SAME - An immediate release formulation of an active ingredient. | 09-29-2011 |
| 20120014912 | PALATABLE PHARMACEUTICAL COMPOSITION - A pharmaceutical formulation comprising: | 01-19-2012 |
| 20120064157 | PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF - The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders and mini-tablets and methods for treating cystic fibrosis employing the pharmaceutical composition. | 03-15-2012 |
Eleni Karayianni, Geneva GR
| Patent application number | Description | Published |
|---|---|---|
| 20110315423 | ABRASION RESISTANT AND FLAME RETARDANT THERMOPLASTIC VULCANIZATE COMPOSITIONS - The present invention relates to flame retardant thermoplastic vulcanizate compositions having improved abrasion resistance and strip force. In addition, the invention relates to wire and cable coated with these compositions. The flame retardant thermoplastic vulcanizate compositions comprise a thermoplastic vulcanizate composition, at least one halogen-free flame retardant and an ultra-high molecular weight polysiloxane. | 12-29-2011 |
Eleni Karayianni, Geneva CH
| Patent application number | Description | Published |
|---|---|---|
| 20090071196 | ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME, AND ARTICLES INCORPORATING THE SAME - An elastic composite yarn comprises a composite core and a composite covering. The composite core comprises an elastic core member and an inelastic functional core member. The composite covering comprises at least an elastic covering member and at least one inelastic covering member surrounding the elastic covering member, such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic core member and the elastic covering member. | 03-19-2009 |
| 20090112079 | TEXTILE-BASED ELECTRODE - Textile-based electrodes include a fabric portion having stretch-recovery non-conductive yarns and an electrically conductive region having stretch-recovery electrically conductive yarn filaments. The electrodes can further include float yarns and can be configured in a textured or ribbed construction. When incorporated into a garment, the electrodes can be used to monitor biophysical characteristics, such as the garment wearer's heart rate. | 04-30-2009 |
| 20090139601 | FUNCTIONAL ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME AND ARTICLES INCORPORATING THE SAME - A functional elastic composite yarn comprises an elastic member that is surrounded by at least one functional covering filament(s). The functional covering filament has a length that is greater than the drafted length of the elastic member such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic member. The elastic composite yarn may further include an optional stress-bearing member surrounding the elastic member and the functional covering filament. | 06-04-2009 |
| 20090145533 | ELECTRICALLY CONDUCTIVE ELASTIC COMPOSITE YARN, METHODS FOR MAKING THE SAME, AND ARTICLES INCORPORATING THE SAME - An electrically conductive elastic composite yarn comprises an elastic member that is surrounded by at least one conductive covering filament(s). The elastic member has a predetermined relaxed unit length L and a predetermined drafted length of (N×L), where N is a number preferably in the range from about 1.0 to about 8.0. The conductive covering filament has a length that is greater than the drafted length of the elastic member such that substantially all of an elongating stress imposed on the composite yarn is carried by the elastic member. The elastic composite yarn may further include an optional stress-bearing member surrounding the elastic member and the conductive covering filament. The length of the stress-bearing member is less than the length of the conductive covering filament and greater than, or equal to, the drafted length (N×L) of the elastic member, such that a portion of the elongating stress imposed on the composite yarn is carried by the stress-bearing member. | 06-11-2009 |
| 20090159149 | SURFACE FUNCTIONAL ELECTRO-TEXTILE WITH FUNCTIONALITY MODULATION CAPABILITY, METHODS FOR MAKING THE SAME, AND APPLICATIONS INCORPORATING THE SAME - A surface functional electro-textile fabric incorporates energy-active, electrically conductive or optically conductive fibers and nonconductive fibers in a woven or knitted textile fabric. The weave or knit pattern is selected so as to form floats of the electrically conductive fibers on at least one surface of the electro-textile fabric. The electro-textile fabric can be incorporated into an antenna structure that interacts with high frequency electromagnetic radiation, particularly in the frequency range of DC to 100 GHz. | 06-25-2009 |
| 20090176091 | Flame retardant thermoplastic elastomer compositions - Flame retardant thermoplastic elastomer composition comprising a thermoplastic vulcanizate composition and non-halogenated flame retardant. | 07-09-2009 |
| 20100230203 | Energy Absorbing Thermoplastic Elastomer - The present invention relates to a method for vibration damping and noise reduction by using thermoplastic vulcanizate compositions and to multilayer structures for use in vibration damping and noise reduction applications comprising at least one polymeric layer made of a thermoplastic vulcanizate composition. | 09-16-2010 |
| 20110288394 | TEXTILE-BASED ELECTRODE - Textile-based electrodes include a fabric portion having stretch-recovery non-conductive yarns and an electrically conductive region having stretch-recovery electrically conductive yarn filaments. The electrodes can further include float yarns and can be configured in a textured or ribbed construction. When incorporated into a garment, the electrodes can be used to monitor biophysical characteristics, such as the garment wearer's heart rate. In addition, two garments with textile based electrodes are disclosed. First, a wrist band for use with a cardiac patient remote monitoring system includes two fabric layers with integral textile-based electrodes. The skin contacting surface of the band includes a conductive region formed as a continuous ring or stripe. A connector links the conductive region to a lead to a device. Second, an infant garment includes textile based electrodes at the torso region and optionally at other regions in order to monitor the infant's biophysical characteristics as the garment is worn. | 11-24-2011 |
Eleni Koutsomitopoulou, Richmond GB
| Patent application number | Description | Published |
|---|---|---|
| 20100195909 | SYSTEM AND METHOD FOR EXTRACTING INFORMATION FROM TEXT USING TEXT ANNOTATION AND FACT EXTRACTION - A fact extraction tool set (“FEX”) finds and extracts targeted pieces of information from text using linguistic and pattern matching technologies, and in particular, text annotation and fact extraction. Text annotation tools break a text, such as a document, into its base tokens and annotate those tokens or patterns of tokens with orthographic, syntactic, semantic, pragmatic and other attributes. A user-defined “Annotation Configuration” controls which annotation tools are used in a given application. XML is used as the basis for representing the annotated text. A tag uncrossing tool resolves conflicting (crossed) annotation boundaries in an annotated text to produce well-formed XML from the results of the individual annotators. The fact extraction tool is a pattern matching language which is used to write scripts that find and match patterns of attributes that correspond to targeted pieces of information in the text, and extract that information. | 08-05-2010 |
Eleni Pratsini, Rueschlikon CH
| Patent application number | Description | Published |
|---|---|---|
| 20110153383 | SYSTEM AND METHOD FOR DISTRIBUTED ELICITATION AND AGGREGATION OF RISK INFORMATION - A method and system for the distributed elicitation and aggregation of risk information is provided. The method comprises selecting a risk network, the risk network comprising one or more risk nodes having associated risk information; assigning a role to each risk node, said role indicating a type of user to evaluate the risk node; generating a customized survey to elicit risk information for a risk node based upon the role and the user, wherein an order of questions in the customized survey presented to the user is determined by an ordering criteria; publishing the customized survey to the user; collecting risk information for the risk node from the user's answers to the customized survey; and populating the risk nodes based on the collected risk information. | 06-23-2011 |
Eleni Stathaki, Pallini Attikis GR
| Patent application number | Description | Published |
|---|---|---|
| 20100137400 | PHARMACEUTICAL FORMULATION CONTAINING AN HMG-COA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to improved pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an HMG-CoA reductase inhibitor, and more particularly Fluvastatin, Atorvastatin or salts thereof in combination with a linear sulphated polysaccharide such as Carrageenan and a method for the preparation thereof. | 06-03-2010 |
| 20110033538 | Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof - The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation. | 02-10-2011 |
| 20110065751 | Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof - The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a selective estrogen receptor modulator, and especially Raloxifene or a pharmaceutical acceptable salt thereof, in combination with a super disintegrant such as Primojel, and a process for the preparation thereof by wet granulation. | 03-17-2011 |
Eleni Tzavara, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110183909 | Treatment of Mood and Anxiety Disorders - The invention relates to a selective inhibitor of Elk-1 or MSK-1 activation for use in the prevention and/or treatment of mood and anxiety disorders. | 07-28-2011 |
Eleni Tzika, Thessaloniki GR
| Patent application number | Description | Published |
|---|---|---|
| 20110045083 | USE LARCH WOOD FOR TREATING INFLAMMATION - The application of raw wood material from a tree of the genus | 02-24-2011 |
Eleni Venetsanakos, Oakland, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100009392 | USE OF MELANOMA INHIBITORY ACTIVITY (MIA) PROTEIN AS AN EARLY INDICATOR FOR THERAPEUTIC RESPONSE IN MELANOMA - The present invention provides a method for determining a response of a mammalian subject having melanoma tumor cells to treatment with a melanoma inhibitory agent. In one aspect, the method comprises (a) determining a first concentration of melanoma inhibitory activity protein (MIA) in a first biological sample taken from the mammalian subject before treatment with the melanoma inhibitory agent; (b) determining a second concentration of MIA in a second biological sample from the mammalian subject taken after treatment with the melanoma inhibitory agent; and (c) comparing the first and second concentrations of MIA, wherein a decrease in the second concentration of MIA measured in the second biological sample as compared to the first concentration of MIA measured in the first biological sample indicates a positive response to the treatment with the melanoma inhibitory agent. | 01-14-2010 |